This year’s forum will bring together industry leaders from the global biotech, healthcare, AI, and investment sectors, including executives and experts from organizations such as Chipscreen Biosciences, Frazier Life Sciences, Protalix Biotherapeutics, Otsuka Pharmaceutical Companies (U.S.), and opAIda. Keynote speeches and panel discussions will focus on topics including cross-border innovation, the application of AI in drug development and clinical research, the biotech financing environment, and opportunities for global collaborations. The forum will also feature several roundtable discussions with guests from biotech companies, investment firms, business development teams, and AI healthcare organizations, who will share practical experiences and real-world challenges facing the industry today. Topics will include AI-driven acceleration of clinical development, cross-border business development and licensing partnerships, biotech financing and exit strategies, global business expansion, and key approaches for advancing innovative therapies from research to clinical validation. The forum aims to provide entrepreneurs, investors, researchers, and industry professionals with a platform for meaningful and practical discussions. As we move into 2026, the global healthcare industry continues to evolve rapidly. AI technologies are increasingly changing the way drug discovery, clinical development, and healthcare data analysis are conducted, while capital markets and international collaboration environments remain uncertain. Against this backdrop, the forum hopes to help attendees stay informed about industry trends, build cross-disciplinary connections, and explore future directions in healthcare innovation. We warmly invite participants from around the world to join us in sharing ideas, exchanging experiences, and exploring new opportunities for collaboration.